vs
NEOGENOMICS INC（NEO）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
NEOGENOMICS INC的季度营收约是REPUBLIC BANCORP INC的2.0倍（$186.7M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs -57.9%，领先82.1%），NEOGENOMICS INC同比增速更快（11.1% vs 5.3%），过去两年NEOGENOMICS INC的营收复合增速更高（6.5% vs -11.5%）
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
NEO vs RBCAA — 直观对比
营收规模更大
NEO
是对方的2.0倍
$94.3M
营收增速更快
NEO
高出5.8%
5.3%
净利率更高
RBCAA
高出82.1%
-57.9%
两年增速更快
NEO
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $186.7M | $94.3M |
| 净利润 | $-108.0M | $22.8M |
| 毛利率 | 43.3% | — |
| 营业利润率 | 46.9% | 29.3% |
| 净利率 | -57.9% | 24.2% |
| 营收同比 | 11.1% | 5.3% |
| 净利润同比 | 42.0% | 20.0% |
| 每股收益（稀释后） | $-0.13 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEORBCAA
| Q1 26 | $186.7M | — | ||
| Q4 25 | $190.2M | $94.3M | ||
| Q3 25 | $187.8M | $93.5M | ||
| Q2 25 | $181.3M | $93.8M | ||
| Q1 25 | $168.0M | $135.8M | ||
| Q4 24 | $172.0M | $89.5M | ||
| Q3 24 | $167.8M | $88.1M | ||
| Q2 24 | $164.5M | $86.9M |
净利润NEORBCAA
| Q1 26 | $-108.0M | — | ||
| Q4 25 | — | $22.8M | ||
| Q3 25 | $-27.1M | $29.7M | ||
| Q2 25 | $-45.1M | $31.5M | ||
| Q1 25 | $-25.9M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-17.7M | $26.5M | ||
| Q2 24 | $-18.6M | $25.2M |
毛利率NEORBCAA
| Q1 26 | 43.3% | — | ||
| Q4 25 | 43.8% | — | ||
| Q3 25 | 42.8% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 43.6% | — | ||
| Q4 24 | 44.9% | — | ||
| Q3 24 | 44.6% | — | ||
| Q2 24 | 44.1% | — |
营业利润率NEORBCAA
| Q1 26 | 46.9% | — | ||
| Q4 25 | -7.1% | 29.3% | ||
| Q3 25 | -14.4% | 40.4% | ||
| Q2 25 | -26.3% | 43.0% | ||
| Q1 25 | -16.6% | 44.1% | ||
| Q4 24 | -10.7% | 25.8% | ||
| Q3 24 | -12.6% | 38.4% | ||
| Q2 24 | -13.3% | 37.0% |
净利率NEORBCAA
| Q1 26 | -57.9% | — | ||
| Q4 25 | — | 24.2% | ||
| Q3 25 | -14.4% | 31.8% | ||
| Q2 25 | -24.9% | 33.5% | ||
| Q1 25 | -15.4% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -10.5% | 30.1% | ||
| Q2 24 | -11.3% | 29.0% |
每股收益（稀释后）NEORBCAA
| Q1 26 | $-0.13 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.1M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $828.8M | $1.1B |
| 总资产 | $1.3B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEORBCAA
| Q1 26 | $146.1M | — | ||
| Q4 25 | $159.6M | $220.0M | ||
| Q3 25 | $164.1M | $484.2M | ||
| Q2 25 | $154.7M | $484.8M | ||
| Q1 25 | $346.2M | $793.0M | ||
| Q4 24 | $367.0M | $432.2M | ||
| Q3 24 | $362.0M | $530.9M | ||
| Q2 24 | $355.1M | $400.1M |
总债务NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | $341.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $541.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NEORBCAA
| Q1 26 | $828.8M | — | ||
| Q4 25 | $836.6M | $1.1B | ||
| Q3 25 | $838.3M | $1.1B | ||
| Q2 25 | $854.0M | $1.1B | ||
| Q1 25 | $888.3M | $1.0B | ||
| Q4 24 | $902.3M | $992.0M | ||
| Q3 24 | $908.2M | $979.7M | ||
| Q2 24 | $915.9M | $955.4M |
总资产NEORBCAA
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $7.0B | ||
| Q3 25 | $1.4B | $7.0B | ||
| Q2 25 | $1.4B | $7.0B | ||
| Q1 25 | $1.6B | $7.1B | ||
| Q4 24 | $1.6B | $6.8B | ||
| Q3 24 | $1.6B | $6.7B | ||
| Q2 24 | $1.6B | $6.6B |
负债/权益比NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流NEORBCAA
| Q1 26 | $-8.1M | — | ||
| Q4 25 | $1.3M | $168.2M | ||
| Q3 25 | $8.9M | $33.3M | ||
| Q2 25 | $20.3M | $8.4M | ||
| Q1 25 | $-25.3M | $93.2M | ||
| Q4 24 | $9.8M | $149.0M | ||
| Q3 24 | $9.2M | $51.3M | ||
| Q2 24 | $13.9M | $4.0M |
自由现金流NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | $-6.5M | $161.1M | ||
| Q3 25 | $570.0K | $30.8M | ||
| Q2 25 | $14.0M | $5.2M | ||
| Q1 25 | $-29.8M | $91.6M | ||
| Q4 24 | $-1.8M | $143.2M | ||
| Q3 24 | $-1.6M | $49.8M | ||
| Q2 24 | $814.0K | $2.7M |
自由现金流率NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | 170.9% | ||
| Q3 25 | 0.3% | 32.9% | ||
| Q2 25 | 7.7% | 5.5% | ||
| Q1 25 | -17.8% | 67.4% | ||
| Q4 24 | -1.0% | 160.0% | ||
| Q3 24 | -0.9% | 56.5% | ||
| Q2 24 | 0.5% | 3.1% |
资本支出强度NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 7.5% | ||
| Q3 25 | 4.4% | 2.6% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 2.7% | 1.2% | ||
| Q4 24 | 6.7% | 6.5% | ||
| Q3 24 | 6.4% | 1.7% | ||
| Q2 24 | 8.0% | 1.5% |
现金转化率NEORBCAA
| Q1 26 | — | — | ||
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
